BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10573782)

  • 21. Nocturnal enuresis.
    Thiedke CC
    Am Fam Physician; 2003 Apr; 67(7):1499-506. PubMed ID: 12722850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasopressin deficiency in primary nocturnal enuresis. Results of a controlled prospective study.
    Steffens J; Netzer M; Isenberg E; Alloussi S; Ziegler M
    Eur Urol; 1993; 24(3):366-70. PubMed ID: 8262104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian variation of plasma arginine vasopressin concentration, or arginine vasopressin in enuresis.
    Aikawa T; Kasahara T; Uchiyama M
    Scand J Urol Nephrol Suppl; 1999; 202():47-9. PubMed ID: 10573793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desmopressin versus desmopressin + oxybutynin in the treatment of children with nocturnal enuresis.
    Gözüküçük A; Kılıç M; Çakıroğlu B
    J Pediatr Urol; 2021 Aug; 17(4):451.e1-451.e6. PubMed ID: 33931318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monosymptomatic Nocturnal Enuresis Treatment Using Alarm-Therapy and Desmopressin: A Meta-analysis Approach.
    Purnomo AF; Daryanto B; Nurhadi P
    Med Arch; 2021 Dec; 75(6):431-435. PubMed ID: 35169370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monosymptomatic nocturnal enuresis in pediatric patients: multidisciplinary assessment and effects of therapeutic intervention.
    Fagundes SN; Lebl AS; Azevedo Soster L; Sousa E Silva GJ; Silvares EF; Koch VH
    Pediatr Nephrol; 2017 May; 32(5):843-851. PubMed ID: 27988804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy with alarm and drugs for monosymptomatic nocturnal enuresis not superior to alarm monotherapy.
    Naitoh Y; Kawauchi A; Yamao Y; Seki H; Soh J; Yoneda K; Mizutani Y; Miki T
    Urology; 2005 Sep; 66(3):632-5. PubMed ID: 16140092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of long-term efficacy of desmopressin lyophilisate and enuretic alarm for monosymptomatic enuresis and assessment of predictive factors for success: a randomized prospective trial.
    Önol FF; Guzel R; Tahra A; Kaya C; Boylu U
    J Urol; 2015 Feb; 193(2):655-61. PubMed ID: 25158273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IERC strategy for characterising nocturnal enuresis. International Enuresis Research Center.
    Schaumburg HL; Schmidt F; Siggaard C; Rittig S; Jørgensen TM; Djurhuus JC
    Scand J Urol Nephrol Suppl; 1999; 202():12-3. PubMed ID: 10573783
    [No Abstract]   [Full Text] [Related]  

  • 30. Monosymptomatic primary enuresis: differences between patients responding or not responding to oral desmopressin.
    Medel R; Dieguez S; Brindo M; Ayuso S; Canepa C; Ruarte A; Podesta ML
    Br J Urol; 1998 May; 81 Suppl 3():46-9. PubMed ID: 9634019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Definitions of subtypes of enuresis.
    Djurhuus JC
    Scand J Urol Nephrol Suppl; 1999; 202():5-7. PubMed ID: 10573781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term home studies of water balance in patients with nocturnal enuresis.
    Rittig S; Schaumburg H; Schmidt F; Hunsballe JM; Hansen AF; Kirk J; Vestergaard P; Djurhuus JC
    Scand J Urol Nephrol Suppl; 1997; 183():25-6; discussion 26-7. PubMed ID: 9165600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Urinary Aquaporin 2 and Plasma Copeptin as Biomarkers of Effectiveness of Desmopressin Acetate for the Treatment of Monosymptomatic Nocturnal Enuresis.
    Hara T; Ohtomo Y; Endo A; Niijima S; Yasui M; Shimizu T
    J Urol; 2017 Oct; 198(4):921-927. PubMed ID: 28457803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of a therapeutic strategy against monosymptomatic nocturnal enuresis].
    Rodríguez do Forno A; Ariceta Iraola G
    An Esp Pediatr; 2001 Jan; 54(1):38-43. PubMed ID: 11181193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can the combined treatment of solifenacin and imipramine has a role in desmopressin refractory monosymptomatic nocturnal enuresis? A prospective double-blind randomized placebo-controlled study.
    Samir M; Mahmoud MA; Elawady H
    Urologia; 2021 Nov; 88(4):369-373. PubMed ID: 33568005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desmopressin resistant nocturnal polyuria may benefit from furosemide therapy administered in the morning.
    De Guchtenaere A; Vande Walle C; Van Sintjan P; Donckerwolcke R; Raes A; Dehoorne J; Van Laecke E; Hoebeke P; Vande Walle J
    J Urol; 2007 Dec; 178(6):2635-9; discussion 2639. PubMed ID: 17945291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of arginine vasopressin in enuretic children under fluid restriction.
    Eggert P; Müller-Schlüter K; Müller D
    Pediatrics; 1999 Feb; 103(2):452-5. PubMed ID: 9925840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The arginine-vasopressin secretion profile of children with primary nocturnal enuresis.
    Aikawa T; Kasahara T; Uchiyama M
    Eur Urol; 1998; 33 Suppl 3():41-4. PubMed ID: 9599737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diurnal plasma vasopressin and urinary output in adolescents with monosymptomatic nocturnal enuresis.
    Läckgren G; Nevéus T; Stenberg A
    Acta Paediatr; 1997 Apr; 86(4):385-90. PubMed ID: 9174225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and management of nocturnal enuresis.
    Gandhi KK
    Curr Opin Pediatr; 1994 Apr; 6(2):194-7. PubMed ID: 8032400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.